President Donald Trump's 18-year-old son, Barron Trump, is already setting his sights on starting his own business enterprise ...

Intel Corporation faces challenges with market share & revenue, but their turnaround plan shows promise. Click for my review ...

On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...

A leaked EU competitiveness strategy is prompting fears that Brussels intends to undermine the independence of the European ...

Viren Merchant’s visionary leadership, coupled with Radhika Merchant’s emerging success, ensures that the family’s ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Ruling parties face hurdles in National Assembly despite having a near 2/3 majority in House of Representatives.

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

The activist investor said it shared the frustrations of those dismayed with the firm's significant discount to net asset ...

To this end, the committee will be engaging with the Minister to seek to understand the exit strategy of the BRPs.